Detection of antibodies to Toxoplasma in sera from patients suffering from recurrent unprovoked seizures were performed using "in-house" indirect hemagglutination assay and by commercially available anti-Toxoplasma immunoglobulin G and immunoglobulin M enzyme-linked immunosorbent assays. Serum antibody to toxoplasmosis were detected in 12.3% and 15.3% by indirect hemagglutination assay and enzyme-linked immunosorbent assays and respectively. Controls showed seropositivity of 5.7% for antibody to Toxoplasma using the same methods. Seropositivity was higher in children compared to adults. No gender differences were noted. Individuals with rural background (living in a relatively unhygienic conditions) were more commonly affected compared to people living in urban areas. (J Pediatr Neurol 2003; 1(2): 95-98).
Introduction
Disease caused by the parasite Toxoplasma gondii (T. gondii) is a health problem world wide and the pattern of disease that follows toxoplasma infection is the result of a balance between the parasite and the host's immune response. There is a wide range of clinical manifestations starting with an acute illness predominantly involving lymphatics, exanthematous conditions or cerebrospinal fluid to fatal infections like toxoplasma encephalitis in human immunodeficiency virus infected patients. Infection especially in a pregnant woman can result in severe morbidity and even death. Moreover, congenital transmission following maternal infection in pregnancy may produce hydrocephalus, chorioretinitis, and intracranial calcifications. There is an increasing awareness that congenital toxoplasmosis can cause a variety of abnormalities both in children and adults (1) . The impact of toxoplasmosis on neurological diseases is not largely known, although some association in certain neurological disorders such as mental retardation, spasticity, cerebral palsy and nerve deafness have been substantially proved (2) . Higher prevalence of epilepsy has been recorded from developing countries compared to industrialized countries through epidemiological surveys (3). Toxoplasmosis being ubiquitous, affects between 5 to 75% of the population in different countries (4) . Incidence studies in both developing and developed countries have shown that a definitive infective etiology of epilepsy can be determined in about 50% of all newly diagnosed cases (5) . Parasitic etiologies of epilepsy, in particular, the helminthic cestode Taenia solium (6) , and onchocerciasis (7) have been established. However, despite high prevalence of T. gondii infection in the general population, little is known about potential possible etiological role of this protozoan in epilepsy.
Isolation of parasite and/or direct demonstration of parasite from affected tissues or organs is the gold standard for diagnosis of toxoplasmosis. But very often it is not successful. Hence, serological investigations are usually employed in most laboratories to establish the diagnosis. Adequate and appropriate serological investigations for toxoplasmosis especially in high risk patients is of paramount importance to take appropriate ORIGINAL ARTICLE
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measures for management and prevention of the disease.
In the present study, prospective serological analysis was carried out to correlate the association between the detail medical data obtained from the patients suffering from recurrent seizures and the presence of anti-Toxoplasma antibody, in order to asses the causal role of T. gondii infection in epilepsy.
Materials and Methods
Sixty-five patients with complaints of recurrent seizures and seventy age and sex matched individuals (controls), suffering from other neurological disorders most unlikely to cause seizures were included in the present study. Particular attentions were paid to age, sex, family history, residential and hygienic conditions, association to pets, early trauma and childhood infections, perinatal difficulties and other relevant clinical information by a detailed questionnaire. A clear history of rashes, lymphadenopathies and other necessary information were also obtained. All these information were obtained together with an informant who had observed the seizures for the description of onset and course of seizures as well as for other illnesses. Occurrence of status epilepticus at any point of time during illness was also considered. All patients underwent a complete physical and neurological examinations. Careful clinical examination and documentation of handedness, presence of hemiplegia, deafness, visual defects, spasticity and ataxia were included. Active epilepsy was defined as two or more afebrile seizures during the previous two years not related to alcohol use, drug intake or acute illnesses (8) . Seizures were categorized to generalized, partial or focal as per standard clinical criteria (9) .
Two to five milliliters of blood without anticoagulant was collected from patients who gave their consent to participate in the study. Serum was separated and was stored at -20 o C until screening for T..gondii antibodies were performed. Anti-Toxoplasma antibodies were detected by both indirect hemagglutination assay (IHA) and commercial enzyme-linked immunosorbent assays (ELISA) anti-Toxoplasma immunoglobulin M (IgM) and immunoglobulin G (IgG) antibody tests. IHA test was performed according to standard protocol (10) in a microtitre plate using tanned sheep red blood cells (SRBCs) sensitized with toxoplasma antigen. Sonicated toxoplasma antigen was prepared by intra-peritoneal inoculation of mice with fresh tachyzoites of T..gondii RH strain and thereafter harvesting the peritoneal fluid and processing for sonication. The antigen obtained was titrated against known anti-Toxoplasma antibody positive sera and was stored at -70 o C until use. Known positive and negative sera were included as reference controls with every test run. Presence of non-specific heterophil antibodies in test and control sera were removed by adsorption with SRBCs and were retested. Specimens giving a positive hemagglutination titre at a dilution of 1:54 or greater and positive ELISA titer (OD values) as per the manufacturers' instructions were considered significant respectively. Control sera were similarly tested using both IHA and ELISA techniques. Additional tests for presence of anti-amoebic and anti-hydatid antibodies were performed with patients' sera (cases and controls) to look for any cross reactivity using both IHA and ELISA techniques.
Five milliliters of blood sample with anticoagulant (EDTA) was also collected from each study individual for baseline investigations such as full blood count, urea and electrolytes, liver functions tests and other routine relevant laboratory (hematological parameters, viral markers) tests. Electroencephalogram (EEG) and neuroimaging investigations were performed in all.
Enrollment of patients for the present study and relevant investigations were carried out after explaining in detail the purpose of the study and thereafter obtaining the written consent from willing individuals. Ethical clearance was duly obtained from research and ethics committee of All India Institute of Medical Sciences.
Results
A total of 65 individuals with a diagnosis of recurrent seizures were included in the present study. There were 40 (61.5%) males and 25 (38.5%) females patients aged from 1-60 years. Twenty-three were children. In a control group (n=70), there were 39 males and 31 females including 24 children. Twenty-one (32.3%) patients had generalized seizures, 29 (44.6%) had focal seizures and 15 had unclassified epileptic seizures. Duration of seizure episodes in these patients ranged from 1 to 10 years. Antibodies to Toxoplasma were found in 8 (12.3%) patients by IHA. Additionally 2 patients including 8 positive by IHA, i.e. total number of 10 (15.3%) patients were positive by IgG ELISA. None of the test sera were positive for IgM antibodies to Toxoplasma . Only four (5.7%) adult patients of control group were positive for antibody to Toxoplasma by both IHA and IgG ELISA. None of the control sera were positive for IgM antibody to Toxoplasma.
The incidence of seropositivity was higher in focal seizures (20.68% by IHA, 27.58% by ELISA) compared to generalized (9.5%) ( Table 1) . Maximum seropositivity was noted in the age group of 1-30 years (n=8 i.e., 21.05%). Antibodies to
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Toxoplasma were detected in 5, out of 23 (21.73%) children, of which 3 (13.03%) developed seizures (focal) between age 1 to 5 years and in 2 (8.7%) developed (generalized seizures) beyond 5 years of age. Seropositive rate was higher in children compared to adults. Individuals living in rural areas had a relatively higher rate of sero-positivity. This could be due to the presumed risk of close contacts with pets or exposure to bad hygienic conditions. Possible etiologic correlations could be made upon analysis of clinical features, duration of epilepsy, EEG and neuroimaging findings in patients who were positive for antibody to Toxoplasma along with the signs of active disease and had seizures. None of the test and control sera showed antibodies crossreactivity for either amoebic or hydatid antigens.
Discussion
Despite advances in many neuroimaging techniques, the etiology of most seizures disorders remains unknown. A detailed account of the seizure from reliable eye witness is most important. Age of the patient at the onset of seizures is important as many of the underlying causes are age-specific and age-related. However, diagnosis of epilepsy in young or old requires the occurrence of recurrent unprovoked seizures. In addition, diagnostic accuracy often depends on the efforts of detailed clinical examinations as well as family history, because in the absence of other risk factors, epilepsy in a first degree relatives increases the risk by a factor of about three (11) . Once a diagnosis of epilepsy is made, it is essential to know the type and cause. Because the prognosis depends heavily on underlying causes. With the increasing incidence of human immunodeficieny virus infection, toxoplasmosis has also become a more important cause of epilepsy in developing countries (12) and the prevalence rate varies from 171 to 978 cases/100,000 (13) .
Upon analysis of both IHA and ELISA results together in the present study, the seropositivity of antibodies to Toxoplasma was found to be higher in patients with seizures than in controls. These findings are in accordance with another study (14) . Although ELISA shows higher sensitivity in the present study, in day to day laboratory practice, IHA has been observed to have almost equal sensitivity in detecting antibody to Toxoplasma. The majority of seropositive individuals were in the age group 1 to 30 years. The incidence of epilepsy is highest during the early years and decreased in later years of life (15) . Males were more commonly affected and had a higher incidence of risk factors. Seizure has been observed as the second commonest presenting symptoms (45%) next to fever (80%) in human immunodeficiey virus patients with toxoplasma encephalitis (16) . As observed in the present study, a majority of patients presented with focal seizures and had a positive titre to IgG Toxoplasma. In a recently carried out study among cryptogenic epileptic patients, a higher seropositive rate for IgG antibodies to Toxoplasma was found in 52% patients compared to 18% healthy volunteers (17) . Thus, the presence of a significant titrate of antibody to Toxoplasma among epileptics compared to patients with other neurological disorders and or healthy controls, strongly emphasizes a casual relationship between T. gondii and seizures.
Although the fact remains, that a positive serological test does not conclusively establish a causal relationship with epilepsy, but an increased incidence of seropositivity certainly form an useful adjunct to clinical and neuroimaging findings. In conclusion, the present study shows that there is a definite association between overt or subclinical toxoplasmosis and recurrent seizures. It is also imperative or indicative of the fact that, individual with seizures should be investigated for toxoplasmosis in addition to other established infectious etiologies. Toxoplasma gondii infection in epilepsy B R Mirdha
